Cites,Authors,Title,Year,Source,Publisher,ArticleURL,CitesURL,GSRank,QueryDate,Type,DOI,ISSN,CitationURL,Volume,Issue,StartPage,EndPage,ECC,CitesPerYear,CitesPerAuthor,AuthorCount,Age,Abstract
13,"E.K. Jensen","Medication before and after a spinal cord lesion",2014,"Spinal Cord","","https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84900298520&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84900298520&origin=inward",3,"2021-01-16 12:22:17","Article","10.1038/sc.2014.20","1362-4393","https://api.elsevier.com/content/abstract/scopus_id/84900298520",52,5,358,363,13,1.86,13,1,7,""
21,"G. Guízar-Sahagún","Lack of neuroprotection with pharmacological pretreatment in a paradigm for anticipated spinal cord lesions",2009,"Spinal Cord","","https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=59749085965&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=59749085965&origin=inward",2,"2021-01-16 12:22:17","Article","10.1038/sc.2008.85","1362-4393","https://api.elsevier.com/content/abstract/scopus_id/59749085965",47,2,156,160,21,1.75,21,1,12,""
67,"A. Rabchevsky","Pharmacological interventions for spinal cord injury: Where do we stand? How might we step forward?",2011,"Pharmacology and Therapeutics","","https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79960570561&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=79960570561&origin=inward",1,"2021-01-16 12:22:17","Review","10.1016/j.pharmthera.2011.05.001","0163-7258","https://api.elsevier.com/content/abstract/scopus_id/79960570561",132,1,15,29,67,6.70,67,1,10,""
